WEBULL
News
BMNDF
0.016
NaN%
--
Weekly Report: what happened at BMNDF last week (0908-0912)?
Weekly Report · 09/15 11:54
Weekly Report: what happened at BMNDF last week (0901-0905)?
Weekly Report · 09/08 11:55
Weekly Report: what happened at BMNDF last week (0825-0829)?
Weekly Report · 09/01 11:50
Weekly Report: what happened at BMNDF last week (0818-0822)?
Weekly Report · 08/25 12:04
Weekly Report: what happened at BMNDF last week (0811-0815)?
Weekly Report · 08/18 11:53
Weekly Report: what happened at BMNDF last week (0804-0808)?
Weekly Report · 08/11 12:03
Weekly Report: what happened at BMNDF last week (0728-0801)?
Weekly Report · 08/04 12:06
Weekly Report: what happened at BMNDF last week (0721-0725)?
Weekly Report · 07/28 12:06
Weekly Report: what happened at BMNDF last week (0714-0718)?
Weekly Report · 07/21 11:54
Weekly Report: what happened at BMNDF last week (0707-0711)?
Weekly Report · 07/14 12:06
Weekly Report: what happened at BMNDF last week (0630-0704)?
Weekly Report · 07/07 11:55
Weekly Report: what happened at BMNDF last week (0623-0627)?
Weekly Report · 06/30 12:03
Weekly Report: what happened at BMNDF last week (0616-0620)?
Weekly Report · 06/23 11:53
Weekly Report: what happened at BMNDF last week (0609-0613)?
Weekly Report · 06/16 12:03
Weekly Report: what happened at BMNDF last week (0602-0606)?
Weekly Report · 06/09 12:04
Weekly Report: what happened at BMNDF last week (0526-0530)?
Weekly Report · 06/02 12:16
Weekly Report: what happened at BMNDF last week (0519-0523)?
Weekly Report · 05/26 12:14
Weekly Report: what happened at BMNDF last week (0512-0516)?
Weekly Report · 05/19 12:02
Weekly Report: what happened at BMNDF last week (0505-0509)?
Weekly Report · 05/12 12:03
Weekly Report: what happened at BMNDF last week (0428-0502)?
Weekly Report · 05/05 12:06
More
Webull provides a variety of real-time BMNDF stock news. You can receive the latest news about Biomind Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About BMNDF
Biomind Labs Inc. is a biotechnology research and development company. The Company is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and innovative nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, the Company is developing novel pharmaceutical formulations of the main psychedelic molecules, N, N-dimethyltryptamine (DMT), 5- MeO-DMT, and mescaline (collectively, the Molecules), for treating a wide range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors, among others. Under the 5-MeO-DMT Program, it is focused on two drug candidates: the BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and the BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.